CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.

Meta Platforms on Thursday announced a lawsuit against a Hong Kong-based company that has managed to work around the social media giant's advertising detection technology to promote AI-powered ...